These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 9205857)

  • 1. Epithelial hyperplasia of usual type expresses both S100-alpha and S100-beta in a heterogeneous pattern but ductal carcinoma in situ can express only S100-alpha in a monotonous pattern.
    Ichihara S; Koshikawa T; Nakamura S; Yatabe Y; Kato K
    Histopathology; 1997 Jun; 30(6):533-41. PubMed ID: 9205857
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Myoepithelial cells and basal lamina in poorly differentiated in situ duct carcinoma of the breast. An immunocytochemical study.
    Damiani S; Ludvikova M; Tomasic G; Bianchi S; Gown AM; Eusebi V
    Virchows Arch; 1999 Mar; 434(3):227-34. PubMed ID: 10190302
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Clinicopathologic features of cystic hypersecretory lesion of the breast].
    Bi R; Cheng Y; Yu B; Shui R; Yang W; Xu X
    Zhonghua Bing Li Xue Za Zhi; 2014 Jan; 43(1):25-9. PubMed ID: 24713245
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Different distributions of immunoreactive S100-alpha and S100-beta protein expression in human breast cancer.
    Funahashi H; Koshikawa T; Ichihara S; Ohike E; Katoh K
    J Surg Oncol; 1998 May; 68(1):25-9. PubMed ID: 9610659
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fine-needle aspiration cytology of ductal hyperplasia with and without atypia and ductal carcinoma in situ.
    Sneige N; Staerkel GA
    Hum Pathol; 1994 May; 25(5):485-92. PubMed ID: 8200642
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Retinoic acid receptor and retinoid X receptor in ductal carcinoma in situ and intraductal proliferative lesions of the human breast.
    Ariga N; Moriya T; Suzuki T; Kimura M; Ohuchi N; Sasano H
    Jpn J Cancer Res; 2000 Nov; 91(11):1169-76. PubMed ID: 11092983
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Papillary neoplasia of the breast: immunohistochemically defined myoepithelial cells in the diagnosis of benign and malignant papillary breast neoplasms.
    Raju UB; Lee MW; Zarbo RJ; Crissman JD
    Mod Pathol; 1989 Nov; 2(6):569-76. PubMed ID: 2479944
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential distribution of ErbB-2 and pS2 proteins in ductal carcinoma in situ of the breast.
    Inaji H; Koyama H; Motomura K; Noguchi S
    Breast Cancer Res Treat; 1996; 37(1):89-92. PubMed ID: 8750531
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Solid papillary ductal carcinoma in situ versus usual ductal hyperplasia in the breast: a potentially difficult distinction resolved by cytokeratin 5/6.
    Rabban JT; Koerner FC; Lerwill MF
    Hum Pathol; 2006 Jul; 37(7):787-93. PubMed ID: 16784976
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preneoplasia of the breast.
    Böcker W
    Verh Dtsch Ges Pathol; 1997; 81():502-13. PubMed ID: 9474891
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Histopathology of myoepithelial (basocellular) hyperplasias in adenosis and epitheliosis of the breast demonstrated by the reactivity of cytokeratins and S100 protein. An analysis of heterogenic cell proliferations in 90 cases of benign and malignant breast diseases.
    Bässler R; Katzer B
    Virchows Arch A Pathol Anat Histopathol; 1992; 421(5):435-42. PubMed ID: 1280883
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression and role of fibroblast activation protein-alpha in microinvasive breast carcinoma.
    Hua X; Yu L; Huang X; Liao Z; Xian Q
    Diagn Pathol; 2011 Nov; 6():111. PubMed ID: 22067528
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ductal carcinoma in situ of the breast. Heterogeneity of individual lesions.
    Lennington WJ; Jensen RA; Dalton LW; Page DL
    Cancer; 1994 Jan; 73(1):118-24. PubMed ID: 8275415
    [TBL] [Abstract][Full Text] [Related]  

  • 14. bcl-2 expression in the spectrum of preinvasive breast lesions.
    Siziopikou KP; Prioleau JE; Harris JR; Schnitt SJ
    Cancer; 1996 Feb; 77(3):499-506. PubMed ID: 8630957
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Similarity in expression of cell cycle proteins between in situ and invasive ductal breast lesions of same differentiation grade.
    Mommers EC; Leonhart AM; Falix F; Michalides R; Meijer CJ; Baak JP; Diest PJ
    J Pathol; 2001 Jul; 194(3):327-33. PubMed ID: 11439365
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relationship of a new histological categorization of ductal carcinoma in situ of the breast with size and the immunohistochemical expression of p53, c-erb B2, bcl-2, and ki-67.
    Mack L; Kerkvliet N; Doig G; O'Malley FP
    Hum Pathol; 1997 Aug; 28(8):974-9. PubMed ID: 9269835
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Psoriasin expression in mammary epithelial cells in vitro and in vivo.
    Enerbäck C; Porter DA; Seth P; Sgroi D; Gaudet J; Weremowicz S; Morton CC; Schnitt S; Pitts RL; Stampl J; Barnhart K; Polyak K
    Cancer Res; 2002 Jan; 62(1):43-7. PubMed ID: 11782356
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential expression of psoriasin messenger RNA between in situ and invasive human breast carcinoma.
    Leygue E; Snell L; Hiller T; Dotzlaw H; Hole K; Murphy LC; Watson PH
    Cancer Res; 1996 Oct; 56(20):4606-9. PubMed ID: 8840971
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Expression of fatty acid synthase and its association with HER2 in invasive ductal carcinoma of breast].
    Yang M; Xu SP; Ao QL
    Zhonghua Bing Li Xue Za Zhi; 2013 Apr; 42(4):257-61. PubMed ID: 23928534
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The evaluation of the immunoexpression of Her2÷neu oncoprotein in ductal carcinoma in situ in association with invasive ductal carcinoma of the breast.
    Fota GL; Stepan A; Ciurea RN
    Rom J Morphol Embryol; 2012; 53(3 Suppl):805-10. PubMed ID: 23188444
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.